Roivant Sciences is seeking FDA decisions regarding its registrational trial for LPP, which is ongoing.

The entities involved

• Roivant Sciences (United States) →

  company in New York, United States

  • Forbes reported on Vivek Ramaswamy's personal wealth being shaped by his stake in Roivant Sciences.Thu 21:52
  • The FCC identified national security concerns involving CITIC subsidiaries, which provided Iran with a $10 billion line of credit.Thu 20:00
• LPP →

  Polish company

  Nothing else this week.

• FDA →
  • The illegal U.S. vape market is estimated to be worth $9 billion, fueled by unauthorized imports from China, while products must meet FDA authorization standards.Sun 20:36
  • VDPHL01 and Veradermics, Incorporated are seeking FDA approval for their lead therapies targeting hair loss.Sun 20:31

Related events

• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7
• EyePoint Pharmaceuticals developed its LUCIA trial program in alignment with the FDA, with enrollment noted in Lugano.Jun 8
• Arise is seeking FDA approval for a drug as of October 7, 2026.Oct 7
• Roivant Sciences and Pharming Group are being compared as healthcare companies that develop medicines in the US and Europe.Oct 14
• FDA provided guidance for HCW Biologics' IND application.Oct 9